You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

TECHNIVIE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Generic Entry Outlook for Technivie

Technivie was eligible for patent challenges on December 19, 2018.

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be April 13, 2032. This may change due to patent challenges or generic licensing.

There have been eight patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.

Indicators of Generic Entry

< Available with Subscription >

  Sign Up

Drug patent expirations by year for TECHNIVIE
Drug Prices for TECHNIVIE

See drug prices for TECHNIVIE

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TECHNIVIE
Generic Entry Date for TECHNIVIE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for TECHNIVIE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AbbViePhase 3
AbbViePhase 2

See all TECHNIVIE clinical trials

US Patents and Regulatory Information for TECHNIVIE

TECHNIVIE is protected by eight US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of TECHNIVIE is ⤷  Sign Up.

This potential generic entry date is based on patent ⤷  Sign Up.

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting TECHNIVIE

Solid pharmaceutical dosage form
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Solid pharmaceutical dosage form
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Macrocyclic hepatitis C serine protease inhibitors
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Macrocyclic hepatitis C serine protease inhibitors
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF HCV INFECTION USING PARITAPREVIR

Solid compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Anti-viral compounds
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Anti-viral compounds
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF HCV INFECTION USING OMBITASVIR

Compositions and methods for treating HCV
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF HCV INFECTION USING PARITAPREVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TECHNIVIE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 ⤷  Sign Up ⤷  Sign Up
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 ⤷  Sign Up ⤷  Sign Up
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 ⤷  Sign Up ⤷  Sign Up
Abbvie TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

EU/EMA Drug Approvals for TECHNIVIE

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
AbbVie Deutschland GmbH Co. KG Viekirax ombitasvir, paritaprevir, ritonavir EMEA/H/C/003839
Viekirax is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults.For hepatitis C virus (HCV) genotype specific activity.
Authorised no no no 2015-01-14
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for TECHNIVIE

When does loss-of-exclusivity occur for TECHNIVIE?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 7060
Estimated Expiration: ⤷  Sign Up

Patent: 3240
Estimated Expiration: ⤷  Sign Up

Patent: 3398
Estimated Expiration: ⤷  Sign Up

Patent: 2505
Estimated Expiration: ⤷  Sign Up

Patent: 4816
Estimated Expiration: ⤷  Sign Up

Australia

Patent: 10258769
Estimated Expiration: ⤷  Sign Up

Patent: 11264823
Estimated Expiration: ⤷  Sign Up

Patent: 11316506
Estimated Expiration: ⤷  Sign Up

Brazil

Patent: 1004894
Estimated Expiration: ⤷  Sign Up

Patent: 2012031500
Estimated Expiration: ⤷  Sign Up

Patent: 2013005701
Estimated Expiration: ⤷  Sign Up

Patent: 2012031500
Estimated Expiration: ⤷  Sign Up

Canada

Patent: 37601
Estimated Expiration: ⤷  Sign Up

Patent: 02180
Estimated Expiration: ⤷  Sign Up

Patent: 07847
Estimated Expiration: ⤷  Sign Up

Patent: 19894
Estimated Expiration: ⤷  Sign Up

Patent: 28495
Estimated Expiration: ⤷  Sign Up

Patent: 47910
Estimated Expiration: ⤷  Sign Up

Patent: 38547
Estimated Expiration: ⤷  Sign Up

Patent: 97170
Estimated Expiration: ⤷  Sign Up

Chile

Patent: 11000689
Estimated Expiration: ⤷  Sign Up

Patent: 12003470
Estimated Expiration: ⤷  Sign Up

Patent: 13000970
Estimated Expiration: ⤷  Sign Up

Patent: 13002299
Estimated Expiration: ⤷  Sign Up

Patent: 14000059
Estimated Expiration: ⤷  Sign Up

China

Patent: 2333772
Estimated Expiration: ⤷  Sign Up

Patent: 3153988
Estimated Expiration: ⤷  Sign Up

Patent: 3172620
Estimated Expiration: ⤷  Sign Up

Patent: 3209686
Estimated Expiration: ⤷  Sign Up

Patent: 3354808
Estimated Expiration: ⤷  Sign Up

Patent: 3596941
Estimated Expiration: ⤷  Sign Up

Patent: 3819459
Estimated Expiration: ⤷  Sign Up

Patent: 3819537
Estimated Expiration: ⤷  Sign Up

Patent: 4193729
Estimated Expiration: ⤷  Sign Up

Patent: 6986861
Estimated Expiration: ⤷  Sign Up

Patent: 8350016
Estimated Expiration: ⤷  Sign Up

Colombia

Patent: 40538
Estimated Expiration: ⤷  Sign Up

Patent: 60490
Estimated Expiration: ⤷  Sign Up

Patent: 61348
Estimated Expiration: ⤷  Sign Up

Costa Rica

Patent: 120650
Estimated Expiration: ⤷  Sign Up

Patent: 130170
Estimated Expiration: ⤷  Sign Up

Patent: 140021
Estimated Expiration: ⤷  Sign Up

Croatia

Patent: 0130671
Estimated Expiration: ⤷  Sign Up

Patent: 0150017
Estimated Expiration: ⤷  Sign Up

Patent: 0150926
Estimated Expiration: ⤷  Sign Up

Patent: 0151389
Estimated Expiration: ⤷  Sign Up

Patent: 0160408
Estimated Expiration: ⤷  Sign Up

Patent: 0181658
Estimated Expiration: ⤷  Sign Up

Cyprus

Patent: 14356
Estimated Expiration: ⤷  Sign Up

Patent: 16060
Estimated Expiration: ⤷  Sign Up

Patent: 16748
Estimated Expiration: ⤷  Sign Up

Patent: 17188
Estimated Expiration: ⤷  Sign Up

Patent: 17456
Estimated Expiration: ⤷  Sign Up

Patent: 22267
Estimated Expiration: ⤷  Sign Up

Patent: 15012
Estimated Expiration: ⤷  Sign Up

Patent: 17031
Estimated Expiration: ⤷  Sign Up

Denmark

Patent: 68890
Estimated Expiration: ⤷  Sign Up

Patent: 55376
Estimated Expiration: ⤷  Sign Up

Patent: 79854
Estimated Expiration: ⤷  Sign Up

Patent: 28481
Estimated Expiration: ⤷  Sign Up

Patent: 92346
Estimated Expiration: ⤷  Sign Up

Patent: 54892
Estimated Expiration: ⤷  Sign Up

Dominican Republic

Patent: 011000087
Estimated Expiration: ⤷  Sign Up

Patent: 012000307
Estimated Expiration: ⤷  Sign Up

Patent: 013000078
Estimated Expiration: ⤷  Sign Up

Patent: 013000185
Estimated Expiration: ⤷  Sign Up

Ecuador

Patent: 11010937
Estimated Expiration: ⤷  Sign Up

Patent: 13010937
Estimated Expiration: ⤷  Sign Up

Patent: 13012382
Estimated Expiration: ⤷  Sign Up

Patent: 13012622
Estimated Expiration: ⤷  Sign Up

Patent: 14012622
Estimated Expiration: ⤷  Sign Up

Patent: 17064986
Estimated Expiration: ⤷  Sign Up

Eurasian Patent Organization

Patent: 0031
Estimated Expiration: ⤷  Sign Up

Patent: 3570
Estimated Expiration: ⤷  Sign Up

Patent: 4100
Estimated Expiration: ⤷  Sign Up

Patent: 4538
Estimated Expiration: ⤷  Sign Up

Patent: 6848
Estimated Expiration: ⤷  Sign Up

Patent: 3332
Estimated Expiration: ⤷  Sign Up

Patent: 1170401
Estimated Expiration: ⤷  Sign Up

Patent: 1291394
Estimated Expiration: ⤷  Sign Up

Patent: 1300495
Estimated Expiration: ⤷  Sign Up

Patent: 1301158
Estimated Expiration: ⤷  Sign Up

Patent: 1390538
Estimated Expiration: ⤷  Sign Up

Patent: 1400115
Estimated Expiration: ⤷  Sign Up

European Patent Office

Patent: 37781
Estimated Expiration: ⤷  Sign Up

Patent: 68890
Estimated Expiration: ⤷  Sign Up

Patent: 55376
Estimated Expiration: ⤷  Sign Up

Patent: 79854
Estimated Expiration: ⤷  Sign Up

Patent: 27651
Estimated Expiration: ⤷  Sign Up

Patent: 28481
Estimated Expiration: ⤷  Sign Up

Patent: 51885
Estimated Expiration: ⤷  Sign Up

Patent: 78334
Estimated Expiration: ⤷  Sign Up

Patent: 92346
Estimated Expiration: ⤷  Sign Up

Patent: 92726
Estimated Expiration: ⤷  Sign Up

Patent: 53531
Estimated Expiration: ⤷  Sign Up

Patent: 54892
Estimated Expiration: ⤷  Sign Up

Patent: 44642
Estimated Expiration: ⤷  Sign Up

Patent: 38106
Estimated Expiration: ⤷  Sign Up

Patent: 56318
Estimated Expiration: ⤷  Sign Up

France

Patent: C1040
Estimated Expiration: ⤷  Sign Up

Guatemala

Patent: 1100074
Estimated Expiration: ⤷  Sign Up

Patent: 1200332
Estimated Expiration: ⤷  Sign Up

Patent: 1300093
Estimated Expiration: ⤷  Sign Up

Patent: 1300093A
Estimated Expiration: ⤷  Sign Up

Hong Kong

Patent: 52620
Estimated Expiration: ⤷  Sign Up

Patent: 61245
Estimated Expiration: ⤷  Sign Up

Patent: 70739
Estimated Expiration: ⤷  Sign Up

Patent: 84068
Estimated Expiration: ⤷  Sign Up

Patent: 86415
Estimated Expiration: ⤷  Sign Up

Patent: 88717
Estimated Expiration: ⤷  Sign Up

Hungary

Patent: 25758
Estimated Expiration: ⤷  Sign Up

Patent: 26832
Estimated Expiration: ⤷  Sign Up

Patent: 28825
Estimated Expiration: ⤷  Sign Up

Patent: 39719
Estimated Expiration: ⤷  Sign Up

Patent: 500019
Estimated Expiration: ⤷  Sign Up

Patent: 700040
Estimated Expiration: ⤷  Sign Up

Israel

Patent: 1792
Estimated Expiration: ⤷  Sign Up

Patent: 3535
Estimated Expiration: ⤷  Sign Up

Patent: 5010
Estimated Expiration: ⤷  Sign Up

Patent: 9248
Estimated Expiration: ⤷  Sign Up

Patent: 3857
Estimated Expiration: ⤷  Sign Up

Patent: 4781
Estimated Expiration: ⤷  Sign Up

Patent: 1206
Estimated Expiration: ⤷  Sign Up

Japan

Patent: 30514
Estimated Expiration: ⤷  Sign Up

Patent: 14356
Estimated Expiration: ⤷  Sign Up

Patent: 34085
Estimated Expiration: ⤷  Sign Up

Patent: 06253
Estimated Expiration: ⤷  Sign Up

Patent: 11838
Estimated Expiration: ⤷  Sign Up

Patent: 22699
Estimated Expiration: ⤷  Sign Up

Patent: 59830
Estimated Expiration: ⤷  Sign Up

Patent: 59736
Estimated Expiration: ⤷  Sign Up

Patent: 86147
Estimated Expiration: ⤷  Sign Up

Patent: 43135
Estimated Expiration: ⤷  Sign Up

Patent: 90202
Estimated Expiration: ⤷  Sign Up

Patent: 12529534
Estimated Expiration: ⤷  Sign Up

Patent: 13528225
Estimated Expiration: ⤷  Sign Up

Patent: 13539791
Estimated Expiration: ⤷  Sign Up

Patent: 14065710
Estimated Expiration: ⤷  Sign Up

Patent: 14144973
Estimated Expiration: ⤷  Sign Up

Patent: 14504296
Estimated Expiration: ⤷  Sign Up

Patent: 14510063
Estimated Expiration: ⤷  Sign Up

Patent: 16106075
Estimated Expiration: ⤷  Sign Up

Patent: 16128456
Estimated Expiration: ⤷  Sign Up

Patent: 17171680
Estimated Expiration: ⤷  Sign Up

Patent: 18065828
Estimated Expiration: ⤷  Sign Up

Patent: 18529671
Estimated Expiration: ⤷  Sign Up

Patent: 19194254
Estimated Expiration: ⤷  Sign Up

Patent: 20059696
Estimated Expiration: ⤷  Sign Up

Patent: 21035964
Estimated Expiration: ⤷  Sign Up

Lithuania

Patent: 368890
Estimated Expiration: ⤷  Sign Up

Patent: 692346
Estimated Expiration: ⤷  Sign Up

Patent: 2017033
Estimated Expiration: ⤷  Sign Up

Patent: 54892
Estimated Expiration: ⤷  Sign Up

Luxembourg

Patent: 0038
Estimated Expiration: ⤷  Sign Up

Patent: 668
Estimated Expiration: ⤷  Sign Up

Malaysia

Patent: 4064
Estimated Expiration: ⤷  Sign Up

Patent: 4607
Estimated Expiration: ⤷  Sign Up

Patent: 6633
Estimated Expiration: ⤷  Sign Up

Mexico

Patent: 9989
Estimated Expiration: ⤷  Sign Up

Patent: 4092
Estimated Expiration: ⤷  Sign Up

Patent: 6264
Estimated Expiration: ⤷  Sign Up

Patent: 11005673
Estimated Expiration: ⤷  Sign Up

Patent: 12014384
Estimated Expiration: ⤷  Sign Up

Patent: 13004150
Estimated Expiration: ⤷  Sign Up

Patent: 13006951
Estimated Expiration: ⤷  Sign Up

Patent: 13009763
Estimated Expiration: ⤷  Sign Up

Patent: 18002707
Estimated Expiration: ⤷  Sign Up

Patent: 20002151
Estimated Expiration: ⤷  Sign Up

Montenegro

Patent: 201
Estimated Expiration: ⤷  Sign Up

Patent: 328
Estimated Expiration: ⤷  Sign Up

Netherlands

Patent: 0731
Estimated Expiration: ⤷  Sign Up

Patent: 0901
Estimated Expiration: ⤷  Sign Up

New Zealand

Patent: 1973
Estimated Expiration: ⤷  Sign Up

Patent: 5440
Estimated Expiration: ⤷  Sign Up

Patent: 6645
Estimated Expiration: ⤷  Sign Up

Patent: 5562
Estimated Expiration: ⤷  Sign Up

Norway

Patent: 15012
Estimated Expiration: ⤷  Sign Up

Patent: 17057
Estimated Expiration: ⤷  Sign Up

Patent: 21039
Estimated Expiration: ⤷  Sign Up

Peru

Patent: 110679
Estimated Expiration: ⤷  Sign Up

Patent: 131036
Estimated Expiration: ⤷  Sign Up

Patent: 140038
Estimated Expiration: ⤷  Sign Up

Patent: 140835
Estimated Expiration: ⤷  Sign Up

Patent: 141083
Estimated Expiration: ⤷  Sign Up

Philippines

Patent: 015500289
Estimated Expiration: ⤷  Sign Up

Poland

Patent: 68890
Estimated Expiration: ⤷  Sign Up

Patent: 55376
Estimated Expiration: ⤷  Sign Up

Patent: 79854
Estimated Expiration: ⤷  Sign Up

Patent: 28481
Estimated Expiration: ⤷  Sign Up

Patent: 92346
Estimated Expiration: ⤷  Sign Up

Patent: 54892
Estimated Expiration: ⤷  Sign Up

Portugal

Patent: 68890
Estimated Expiration: ⤷  Sign Up

Patent: 55376
Estimated Expiration: ⤷  Sign Up

Patent: 79854
Estimated Expiration: ⤷  Sign Up

Patent: 92346
Estimated Expiration: ⤷  Sign Up

Patent: 54892
Estimated Expiration: ⤷  Sign Up

San Marino

Patent: 01500263
Estimated Expiration: ⤷  Sign Up

Serbia

Patent: 854
Estimated Expiration: ⤷  Sign Up

Patent: 856
Estimated Expiration: ⤷  Sign Up

Patent: 282
Estimated Expiration: ⤷  Sign Up

Patent: 619
Estimated Expiration: ⤷  Sign Up

Patent: 790
Estimated Expiration: ⤷  Sign Up

Patent: 982
Estimated Expiration: ⤷  Sign Up

Singapore

Patent: 1708
Estimated Expiration: ⤷  Sign Up

Patent: 6251
Estimated Expiration: ⤷  Sign Up

Patent: 8951
Estimated Expiration: ⤷  Sign Up

Patent: 201702522U
Estimated Expiration: ⤷  Sign Up

Slovenia

Patent: 68890
Estimated Expiration: ⤷  Sign Up

Patent: 55376
Estimated Expiration: ⤷  Sign Up

Patent: 79854
Estimated Expiration: ⤷  Sign Up

Patent: 28481
Estimated Expiration: ⤷  Sign Up

Patent: 92346
Estimated Expiration: ⤷  Sign Up

Patent: 54892
Estimated Expiration: ⤷  Sign Up

South Africa

Patent: 1102425
Estimated Expiration: ⤷  Sign Up

Patent: 1203502
Estimated Expiration: ⤷  Sign Up

Patent: 1203503
Estimated Expiration: ⤷  Sign Up

Patent: 1300112
Estimated Expiration: ⤷  Sign Up

Patent: 1302269
Estimated Expiration: ⤷  Sign Up

Patent: 1705519
Estimated Expiration: ⤷  Sign Up

Patent: 1903284
Estimated Expiration: ⤷  Sign Up

South Korea

Patent: 1452916
Estimated Expiration: ⤷  Sign Up

Patent: 1481395
Estimated Expiration: ⤷  Sign Up

Patent: 1586215
Estimated Expiration: ⤷  Sign Up

Patent: 1677481
Estimated Expiration: ⤷  Sign Up

Patent: 1831154
Estimated Expiration: ⤷  Sign Up

Patent: 1990936
Estimated Expiration: ⤷  Sign Up

Patent: 2059386
Estimated Expiration: ⤷  Sign Up

Patent: 120117620
Estimated Expiration: ⤷  Sign Up

Patent: 130053440
Estimated Expiration: ⤷  Sign Up

Patent: 140032338
Estimated Expiration: ⤷  Sign Up

Patent: 140037974
Estimated Expiration: ⤷  Sign Up

Patent: 140143152
Estimated Expiration: ⤷  Sign Up

Patent: 150008151
Estimated Expiration: ⤷  Sign Up

Patent: 180023014
Estimated Expiration: ⤷  Sign Up

Patent: 180026775
Estimated Expiration: ⤷  Sign Up

Spain

Patent: 14934
Estimated Expiration: ⤷  Sign Up

Patent: 11440
Estimated Expiration: ⤷  Sign Up

Patent: 26908
Estimated Expiration: ⤷  Sign Up

Patent: 46767
Estimated Expiration: ⤷  Sign Up

Patent: 60842
Estimated Expiration: ⤷  Sign Up

Patent: 65536
Estimated Expiration: ⤷  Sign Up

Patent: 24246
Estimated Expiration: ⤷  Sign Up

Patent: 91625
Estimated Expiration: ⤷  Sign Up

Taiwan

Patent: 02070
Estimated Expiration: ⤷  Sign Up

Patent: 19874
Estimated Expiration: ⤷  Sign Up

Patent: 69780
Estimated Expiration: ⤷  Sign Up

Patent: 86159
Estimated Expiration: ⤷  Sign Up

Patent: 87700
Estimated Expiration: ⤷  Sign Up

Patent: 86660
Estimated Expiration: ⤷  Sign Up

Patent: 21611
Estimated Expiration: ⤷  Sign Up

Patent: 1102063
Estimated Expiration: ⤷  Sign Up

Patent: 1204713
Estimated Expiration: ⤷  Sign Up

Patent: 1238948
Estimated Expiration: ⤷  Sign Up

Patent: 1247648
Estimated Expiration: ⤷  Sign Up

Patent: 1334778
Estimated Expiration: ⤷  Sign Up

Patent: 1347759
Estimated Expiration: ⤷  Sign Up

Patent: 1412707
Estimated Expiration: ⤷  Sign Up

Patent: 1519891
Estimated Expiration: ⤷  Sign Up

Turkey

Patent: 1815161
Estimated Expiration: ⤷  Sign Up

Ukraine

Patent: 3052
Estimated Expiration: ⤷  Sign Up

Patent: 5434
Estimated Expiration: ⤷  Sign Up

Patent: 8904
Estimated Expiration: ⤷  Sign Up

Patent: 3048
Estimated Expiration: ⤷  Sign Up

Patent: 8080
Estimated Expiration: ⤷  Sign Up

Uruguay

Patent: 699
Estimated Expiration: ⤷  Sign Up

Patent: 446
Estimated Expiration: ⤷  Sign Up

Patent: 667
Estimated Expiration: ⤷  Sign Up

Patent: 983
Estimated Expiration: ⤷  Sign Up

Patent: 266
Estimated Expiration: ⤷  Sign Up

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering TECHNIVIE around the world.

Country Patent Number Title Estimated Expiration
Eurasian Patent Organization 024100 МЕТИЛ {(2S,3R)-1-[(2S)-2-{5-[(2R,5R)-1-{3,5-ДИФТОР-4-[4-(4-ФТОРФЕНИЛ)ПИПЕРИДИН-1-ИЛ]ФЕНИЛ}-5-(6-ФТОР-2-{(2S)-1-[N-(МЕТОКСИКАРБОНИЛ)-О-МЕТИЛ-L-ТРЕОНИЛ]ПИРРОЛИДИН-2-ИЛ}-1H-БЕНЗИМИДАЗОЛ-5-ИЛ)ПИРРОЛИДИН-2-ИЛ]-6-ФТОР-1H-БЕНЗИМИДАЗОЛ-2-ИЛ}ПИРРОЛИДИН-2-ИЛ]-3-МЕТОКСИ-1-ОКСОБУТАН-2-ИЛ}КАРБАМАТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ ЕГО, И СПОСОБ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА C (METHYL {(2S,3R)-1-[(2S)-2-{5-[(2R,5R)-1-{3,5-DIFLUORO-4-[4-(4-FLUOROPHENYL)PIPERIDIN-1-YL]PHENYL}-5-(6-FLUORO-2-{(2S)-1-[N-(METHOXYCARBONYL)-O-METHYL-L-THREONYL]PYRROLIDIN-2-yl}-1H-BENZIMIDAZOL-5-YL)PYRROLIDIN-2-YL]-6-FLUORO-1H-BENZIMIDAZOL-2-YL}PYRROLIDIN-1-YL]-3-METHOXY-1-OXOBUTAN-2-YL}CARBAMATE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND METHOD OF TREATING HCV INFECTION) ⤷  Sign Up
Spain 2560842 ⤷  Sign Up
Hungary E025758 ⤷  Sign Up
Taiwan 201412707 Anti-viral compounds ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for TECHNIVIE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2340029 15C0021 France ⤷  Sign Up PRODUCT NAME: PARITAPREVIR DANS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; REGISTRATION NO/DATE: EU/1/14/982 20150119
2368890 CR 2015 00015 Denmark ⤷  Sign Up PRODUCT NAME: OMBITASVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF; REG. NO/DATE: EU/1/14/982 20150119
2692346 1790050-7/1791051-4 Sweden ⤷  Sign Up PRODUCT NAME: PIBRENTASVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.
2368890 33/2015 Austria ⤷  Sign Up PRODUCT NAME: OMBITASVIR, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/14/982 (MITTEILUNG) 20150119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.